{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:27:09Z","timestamp":1785209229018,"version":"3.55.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2022R1A2C1010017"],"award-info":[{"award-number":["2022R1A2C1010017"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2023-00248980"],"award-info":[{"award-number":["RS-2023-00248980"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jconrel.2025.01.019","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T20:55:47Z","timestamp":1736974547000},"page":"390-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Human serum albumin-3-amino-1-propanesulfonic acid conjugate inhibits amyloid-\u03b2 aggregation and mitigates cognitive decline in Alzheimer's disease"],"prefix":"10.1016","volume":"379","author":[{"given":"Divya","family":"Shastri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitany Jayprakash","family":"Raorane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinit","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangkil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.01.019_bb0005","doi-asserted-by":"crossref","first-page":"15437","DOI":"10.1021\/jacs.7b08584","article-title":"Molecular insights into human serum albumin as a receptor of amyloid-\u03b2 in the extracellular region","volume":"139","author":"Choi","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0010","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1021\/acsmacrolett.1c00525","article-title":"Conformation control of amyloid filaments by repeated thermal perturbation","volume":"10","author":"Lee","year":"2021","journal-title":"ACS Macro Lett."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173554","article-title":"Alzheimer\u2019s disease: recent treatment strategies","volume":"887","author":"Vaz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0020","article-title":"Alzheimer\u2019s disease drug development pipeline: 2020","volume":"6","author":"Cummings","year":"2020","journal-title":"Alzheimer\u2019s & Dementia: Transl. Res. Clin. Intervent."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101496","article-title":"Past, present and future of therapeutic strategies against amyloid-\u03b2 peptides in Alzheimer\u2019s disease: a systematic review","volume":"72","author":"Jeremic","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.conb.2020.02.003","article-title":"Amyloid \u03b2-protein and beyond: the path forward in Alzheimer\u2019s disease","volume":"61","author":"Walsh","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007409","article-title":"The economic burden of dementia in low-and middle-income countries (LMICs): a systematic review","volume":"7","author":"Mattap","year":"2022","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clinbiochem.2019.04.015","article-title":"Clinical aspects of Alzheimer\u2019s disease","volume":"72","author":"Zv\u011b\u0159ov\u00e1","year":"2019","journal-title":"Clin. Biochem."},{"issue":"2019","key":"10.1016\/j.jconrel.2025.01.019_bb0045","first-page":"321","article-title":"Alzheimer\u2019s disease facts and figures","volume":"15","author":"A. Association","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/cells9020349","article-title":"Curcumin derivative GT863 inhibits amyloid-beta production via inhibition of protein N-glycosylation","volume":"9","author":"Urano","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240378","article-title":"Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation","volume":"15","author":"Okuda","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0060","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1370\/afm.3050","article-title":"Clinically important benefits and harms of monoclonal antibodies targeting amyloid for the treatment of Alzheimer disease: a systematic review and Meta-analysis, the","volume":"22","author":"Ebell","year":"2024","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0065","first-page":"497","article-title":"Potential Alzheimer\u2019s disease therapeutic nano-platform: discovery of amyloid-beta plaque disaggregating agent and brain-targeted delivery system using porous silicon nanoparticles","volume":"24","author":"Kim","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.actbio.2022.11.058","article-title":"Emerging albumin hydrogels as personalized biomaterials","volume":"157","author":"Kong","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0075","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/acs.molpharmaceut.1c00046","article-title":"The uniqueness of albumin as a carrier in nanodrug delivery","volume":"18","author":"Spada","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0080","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s11095-021-03093-x","article-title":"Lipophilic conjugates of drugs: a tool to improve drug pharmacokinetic and therapeutic profiles","volume":"38","author":"Han","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0085","first-page":"930","article-title":"Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance","volume":"3","author":"Hassanin","year":"2020","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0090","doi-asserted-by":"crossref","first-page":"102379","DOI":"10.1016\/j.arr.2024.102379","article-title":"Revolutionizing Alzheimer\u2019s treatment: harnessing human serum albumin for targeted drug delivery and therapy advancements","volume":"99","author":"Shastri","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0095","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41467-024-44818-x","article-title":"Early onset diagnosis in Alzheimer\u2019s disease patients via amyloid-\u03b2 oligomers-sensing probe in cerebrospinal fluid","volume":"15","author":"An","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103164","article-title":"Emerging insights into the role of albumin with plasma exchange in Alzheimer\u2019s disease management","volume":"60","author":"Costa","year":"2021","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0105","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1039\/D0CC01384F","article-title":"Human serum albumin-mediated recognition of soluble amyloid-\u03b2 peptides using a time-resolved luminescent probe in plasma","volume":"56","author":"Yuan","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0110","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1212\/WNL.0000000000010005","article-title":"Serum albumin and beta-amyloid deposition in the human brain","volume":"95","author":"Kim","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0115","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s12257-019-0512-9","article-title":"Albumin: an emerging opportunity in drug delivery","volume":"25","author":"Rahimizadeh","year":"2020","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0120","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fneur.2020.00614","article-title":"A review on tramiprosate (Homotaurine) in alzheimer\u2019s disease and other neurocognitive disorders","volume":"11","author":"Manzano","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/md19050251","article-title":"Anti-Alzheimer\u2019s molecules derived from marine life: understanding molecular mechanisms and therapeutic potential","volume":"19","author":"Kabir","year":"2021","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1271203","article-title":"GABAA receptors as plausible molecular targets and mediators for taurine and homotaurine actions","volume":"14","author":"Meera","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0135","article-title":"Tramiprosate (Alzhemed) for Alzheimer\u2019s disease","volume":"2018","author":"Malouf","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/14728214.2020.1808621","article-title":"Anti-amyloid-\u03b2 protein agents for the treatment of Alzheimer\u2019s disease: an update on emerging drugs","volume":"25","author":"Lozupone","year":"2020","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.813951","article-title":"IL-33 and IL-10 serum levels increase in MCI patients following homotaurine treatment","volume":"13","author":"Toppi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0150","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.3390\/ijms23169305","article-title":"Symptomatic and disease-modifying therapy pipeline for Alzheimer\u2019s disease: towards a personalized polypharmacology patient-centered approach","volume":"23","author":"Morat\u00f3","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0155","first-page":"219","article-title":"Clinical benefits of tramiprosate in Alzheimer\u2019s disease are associated with higher number of APOE4 alleles: the \u201cAPOE4 Gene-Dose Effect,\u201d","volume":"3","author":"Abushakra","year":"2016","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40262-017-0608-3","article-title":"Clinical pharmacokinetics and safety of ALZ-801, a novel prodrug of tramiprosate in development for the treatment of Alzheimer\u2019s disease","volume":"57","author":"Hey","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0165","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2310\/7290.2009.00021","article-title":"Comparative analysis of nanoparticle-antibody conjugations: carbodiimide versus click chemistry","volume":"8","author":"Thorek","year":"2009","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0170","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijpharm.2008.01.019","article-title":"A liposomal formulation study of 2,7-dichlorodihydrofluorescein for detection of reactive oxygen species","volume":"356","author":"Sadzuka","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0175","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1515\/tnsci-2022-0243","article-title":"Protection against H2O2-evoked toxicity in HT22 hippocampal neuronal cells by geissoschizine methyl ether via inhibiting ERK pathway","volume":"13","author":"Hu","year":"2022","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0180","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/jnr.23964","article-title":"Limitations of the hCMEC\/D3 cell line as a model for A\u03b2 clearance by the human blood-brain barrier","volume":"95","author":"Biemans","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0185","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Autom."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-8118-10-16","article-title":"The hCMEC\/D3 cell line as a model of the human blood brain barrier","volume":"10","author":"Weksler","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0195","article-title":"BBB pathophysiology\u2013independent delivery of siRNA in traumatic brain injury","volume":"7","author":"Li","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuro.2020.12.015","article-title":"Neuroprotective effects of carbenoxolone against amyloid-beta 1\u201342 oligomer-induced neuroinflammation and cognitive decline in rats","volume":"83","author":"Sharma","year":"2021","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0205","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/etc.204","article-title":"Determining the molecular interactions of perfluorinated carboxylic acids with human sera and isolated human serum albumin using nuclear magnetic resonance spectroscopy","volume":"29","author":"D\u2019eon","year":"2010","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0210","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/biol.1998.0163","article-title":"Recombinant human albumin as a stabilizer for biological materials and for the preparation of international reference reagents","volume":"26","author":"Tarelli","year":"1998","journal-title":"Biologicals"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0215","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0167-4838(86)90054-3","article-title":"A proton nuclear magnetic resonance study of human serum albumin in the neutral pH region","volume":"873","author":"Labro","year":"1986","journal-title":"Biochim. Biophys. Acta (BBA)-Protein Struct. Mol. Enzymol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0220","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nprot.2015.024","article-title":"Obtaining information about protein secondary structures in aqueous solution using Fourier transform IR spectroscopy","volume":"10","author":"Yang","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0225","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jssc.2007.12.017","article-title":"Synthesis and characterization of sulfonated single-walled carbon nanotubes and their performance as solid acid catalyst","volume":"181","author":"Yu","year":"2008","journal-title":"J. Solid State Chem."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0230","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1021\/cs300103k","article-title":"Amorphous carbon with SO3H groups as a solid Br\u00f8nsted acid catalyst","volume":"2","author":"Nakajima","year":"2012","journal-title":"ACS Catal."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1208\/s12249-013-0041-3","article-title":"Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy","volume":"15","author":"Ding","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0240","first-page":"245","article-title":"21 X-ray diffraction analysis of biochar","author":"Singh","year":"2017","journal-title":"Biochar: Guide Anal. Methods"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0245","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1021\/la030407s","article-title":"Synthesis and characterization of active ester-functionalized polypyrrole\u2212 silica nanoparticles: application to the covalent attachment of proteins","volume":"20","author":"Azioune","year":"2004","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0250","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/pharmaceutics11070297","article-title":"Potential albumin-based antioxidant nanoformulations for ocular protection against oxidative stress","volume":"11","author":"Kim","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036723","article-title":"Locating the binding sites of Pb (II) ion with human and bovine serum albumins","volume":"7","author":"Belatik","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-017-0348-3","article-title":"Study on the interaction of paeoniflorin with human serum albumin (HSA) by spectroscopic and molecular docking techniques","volume":"11","author":"Xu","year":"2017","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0265","first-page":"525","article-title":"Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis","author":"Sebak","year":"2010","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0270","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1021\/acsami.5b00915","article-title":"Design of LVFFARK and LVFFARK-functionalized nanoparticles for inhibiting amyloid \u03b2-protein fibrillation and cytotoxicity","volume":"7","author":"Xiong","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0275","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1021\/acschemneuro.8b00440","article-title":"D-enantiomeric rthlvffark-NH2: a potent multifunctional decapeptide inhibiting Cu2+\u2212mediated amyloid \u03b2-protein aggregation and remodeling Cu2+\u2212mediated amyloid \u03b2 aggregates","volume":"10","author":"Liu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0280","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and tau in the pathogenesis of Alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0285","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.biopsych.2014.12.019","article-title":"Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies","volume":"78","author":"Sengupta","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0290","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0295","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1073\/pnas.1630428100","article-title":"Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer\u2019s disease","volume":"100","author":"Gamblin","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0300","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0305","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.R800019200","article-title":"Amyloid precursor protein trafficking, processing, and function","volume":"283","author":"Thinakaran","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0310","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bpj.2010.11.037","article-title":"Stoichiometry and affinity of the human serum albumin-Alzheimer\u2019s A\u03b2 peptide interactions","volume":"100","author":"Milojevic","year":"2011","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0315","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jmb.2018.01.008","article-title":"Serum Albumin\u2019s protective inhibition of amyloid-\u03b2 Fiber formation is suppressed by cholesterol, fatty acids and warfarin","volume":"430","author":"Bode","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0320","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40263-017-0434-z","article-title":"Elucidating the A\u03b242 anti-aggregation mechanism of action of tramiprosate in Alzheimer\u2019s disease: integrating molecular analytical methods, pharmacokinetic and clinical data","volume":"31","author":"Kocis","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0325","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1021\/acsnano.6b04268","article-title":"Blood\u2013brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy","volume":"10","author":"Lin","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0330","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neurobiolaging.2006.02.015","article-title":"Targeting soluble A\u03b2 peptide with Tramiprosate for the treatment of brain amyloidosis","volume":"28","author":"Gervais","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0335","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/cb400080f","article-title":"Untangling amyloid-\u03b2, tau, and metals in Alzheimer\u2019s disease","volume":"8","author":"Savelieff","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0340","doi-asserted-by":"crossref","first-page":"97","DOI":"10.14283\/jpad.2023.61","article-title":"Burden of illness in people with Alzheimer\u2019s disease: a systematic review of epidemiology, comorbidities and mortality","volume":"11","author":"Lanct\u00f4t","year":"2024","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0345","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer\u2019s disease drug development pipeline: 2019","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimer\u2019s & Dement.: Transl. Res. Clin. Intervent."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0350","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/d41586-024-00756-8","article-title":"Researchers call for a major rethink of how Alzheimer\u2019s treatments are evaluated","volume":"627","author":"Landhuis","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0355","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","article-title":"Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer\u2019s disease","volume":"618","author":"Depp","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0360","series-title":"Neurobiology of Brain Disorders","first-page":"313","article-title":"Alzheimer diseases","author":"Savonenko","year":"2023"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107461","article-title":"Anti-amyloid: An antibody to cure Alzheimer\u2019s or an attitude","volume":"26","author":"Osborne","year":"2023","journal-title":"IScience"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0370","first-page":"1","article-title":"Anti-amyloid therapies for Alzheimer\u2019s disease: an Alzheimer Europe position paper and call to action","author":"Bradshaw","year":"2024","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0609-7","article-title":"Clinical trials of new drugs for Alzheimer disease","volume":"27","author":"Huang","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0380","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: physiology and strategies for drug delivery","volume":"165","author":"Pandit","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0390","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1083\/jcb.105.6.2603","article-title":"Transcytosis of albumin in capillary endothelium","volume":"105","author":"Milici","year":"1987","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0395","doi-asserted-by":"crossref","first-page":"25968","DOI":"10.1074\/jbc.272.41.25968","article-title":"Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway","volume":"272","author":"Tiruppathi","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0400","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1016\/S0021-9258(17)37571-3","article-title":"Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins","volume":"269","author":"Schnitzer","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0405","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/1050-1738(93)90012-U","article-title":"Update on the cellular and molecular basis of capillary permeability","volume":"3","author":"Schnitzer","year":"1993","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0410","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jalz.2019.09.075","article-title":"The path forward in Alzheimer\u2019s disease therapeutics: reevaluating the amyloid cascade hypothesis","volume":"16","author":"Tolar","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0415","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-020-00663-w","article-title":"Aducanumab, gantenerumab, BAN2401, and ALZ-801\u2014the first wave of amyloid-targeting drugs for Alzheimer\u2019s disease with potential for near term approval","volume":"12","author":"Tolar","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0420","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijbiomac.2021.07.080","article-title":"The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy","volume":"187","author":"Tao","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ultsonch.2021.105617","article-title":"Characterization of sonochemically prepared human serum albumin nanocapsules using different plant oils as core component for targeted drug delivery","volume":"76","author":"Skoll","year":"2021","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0430","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1021\/acsanm.2c01596","article-title":"4-Oxo-fenretinide-loaded human serum albumin nanoparticles for the inhibition of epithelial\u2013mesenchymal transition in neuroblastoma xenografts","volume":"5","author":"Dev","year":"2022","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0435","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3390\/nu13082704","article-title":"Nutritional supplements and neuroprotective diets and their potential clinical significance in post-stroke rehabilitation","volume":"13","author":"Zieli\u0144ska-Nowak","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2110-5820-3-4","article-title":"Specific antioxidant properties of human serum albumin","volume":"3","author":"Taverna","year":"2013","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0445","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40263-018-0554-0","article-title":"Discovery and identification of an endogenous metabolite of tramiprosate and its prodrug ALZ-801 that inhibits beta amyloid oligomer formation in the human brain","volume":"32","author":"Hey","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0450","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.csbj.2019.06.017","article-title":"Human albumin impairs amyloid \u03b2-peptide fibrillation through its C-terminus: from docking modeling to protection against neurotoxicity in alzheimer\u2019s disease","volume":"17","author":"Pic\u00f3n-Pag\u00e8s","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0455","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.1021\/acsnano.3c05011","article-title":"Engineered selenium\/human serum albumin nanoparticles for efficient targeted treatment of Parkinson\u2019s disease via oral gavage","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112935","article-title":"Increased blood-brain barrier permeability of neuroprotective drug by colloidal serum albumin carriers","volume":"220","author":"Hornok","year":"2022","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0465","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","article-title":"The antioxidant properties of serum albumin","volume":"582","author":"Roche","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0470","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0475","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/ars.2010.3733","article-title":"Mitogen-activated protein kinases in mammalian oxidative stress responses","volume":"15","author":"Runchel","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0480","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/antiox11061101","article-title":"Silibinin protects against H2O2-induced oxidative damage in SH-SY5Y cells by improving mitochondrial function","volume":"11","author":"Tie","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0485","doi-asserted-by":"crossref","first-page":"15743","DOI":"10.1039\/D0NR01627F","article-title":"Quantifying the level of nanoparticle uptake in mammalian cells using flow cytometry","volume":"12","author":"Shin","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-015-0082-8","article-title":"Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model","volume":"13","author":"Noorani","year":"2015","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0495","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/iub.2653","article-title":"Serum albumin and nucleic acids biodistribution: from molecular aspects to biotechnological applications","volume":"74","author":"Vita","year":"2022","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0500","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/ard.1995.5.213","article-title":"Bovine serum albumin is a major oligonucleotide-binding protein found on the surface of cultured cells","volume":"5","author":"Geselowitz","year":"1995","journal-title":"Antisense Res. Dev."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0505","doi-asserted-by":"crossref","first-page":"24544","DOI":"10.1016\/S0021-9258(18)35799-5","article-title":"Preferential interaction of albumin-binding proteins, gp30 and gp18, with conformationally modified albumins. Presence in many cells and tissues with a possible role in catabolism","volume":"267","author":"Schnitzer","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0510","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2010050492","article-title":"Cubilin is essential for albumin reabsorption in the renal proximal tubule","volume":"21","author":"Amsellem","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0515","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1172\/JCI8862","article-title":"Cubilin is an albumin binding protein important for renal tubular albumin reabsorption","volume":"105","author":"Birn","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0520","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.20021829","article-title":"The major histocompatibility complex\u2013related fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan","volume":"197","author":"Chaudhury","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0525","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.colsurfb.2019.06.035","article-title":"Selection of fluorescent dye for tracking biodistribution of paclitaxel in live imaging","volume":"181","author":"Shuai","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0530","series-title":"Nanoparticle Therapeutics","first-page":"327","article-title":"Albumin nanoparticles\u2014A versatile and a safe platform for drug delivery applications","author":"Zwain","year":"2022"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0535","first-page":"3203","article-title":"Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure","author":"Lee","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0540","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":"Tumor paint: a chlorotoxin: Cy5. 5 bioconjugate for intraoperative visualization of cancer foci","volume":"67","author":"Veiseh","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0545","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1039\/C8SC04318C","article-title":"The biobehavior, biocompatibility and theranostic application of SPNS and Pd@ au nanoplates in rats and rabbits","volume":"10","author":"Li","year":"2019","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0550","doi-asserted-by":"crossref","first-page":"12310","DOI":"10.1021\/nn5062386","article-title":"Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapy","volume":"8","author":"Sheng","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0555","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1021\/acs.jmedchem.1c01790","article-title":"Developing a novel indium (III) agent based on human serum albumin nanoparticles: integrating bioimaging and therapy","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0560","doi-asserted-by":"crossref","first-page":"30373","DOI":"10.1021\/acsami.1c07281","article-title":"Natural phyto-antioxidant albumin nanoagents to treat advanced Alzheimer\u2019s disease","volume":"13","author":"Dou","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0565","first-page":"e897","article-title":"Morris water maze experiment","volume":"19","author":"Nunez","year":"2008","journal-title":"JoVE (Visual. Exper.)"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0570","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1460-9568.1999.00408.x","article-title":"Protective effects of idebenone and \u03b1-tocopherol on \u03b2-amyloid-(1\u201342)-induced learning and memory deficits in rats: implication of oxidative stress in \u03b2-amyloid-induced neurotoxicity in vivo","volume":"11","author":"Yamada","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0575","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0006-8993(01)02704-4","article-title":"Progressive brain dysfunction following intracerebroventricular infusion of beta1\u201342-amyloid peptide","volume":"912","author":"Nakamura","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0580","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bjp.0702309","article-title":"Improvement by nefiracetam of \u03b2-amyloid-(1-42)-induced learning and memory impairments in rats","volume":"126","author":"Yamada","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0585","article-title":"Curcumin improves amyloid \u03b2-peptide (1-42) induced spatial memory deficits through BDNF-ERK signaling pathway","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0590","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2010.09.076","article-title":"Anti-neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer disease","volume":"487","author":"Wang","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0595","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1134\/S2079086424010109","article-title":"Role of human serum albumin in the prevention and treatment of Alzheimer\u2019s disease","volume":"14","author":"Shevelyova","year":"2024","journal-title":"Biol. Bull. Rev."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0600","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1021\/acschemneuro.1c00150","article-title":"Multipronged regulatory functions of serum albumin in early stages of amyloid-\u03b2 aggregation","volume":"12","author":"Zhao","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0605","first-page":"1","article-title":"Human serum albumin (HSA) and its applications as a drug delivery vehicle","volume":"14","author":"Wang","year":"2020","journal-title":"Health Sci. J."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0610","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.bbagen.2013.04.023","article-title":"Albumin as a versatile platform for drug half-life extension","volume":"1830","author":"Sleep","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Gener. Subj."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0615","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1517\/14656566.7.8.1041","article-title":"Albumin-bound paclitaxel: a next-generation taxane","volume":"7","author":"Gradishar","year":"2006","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0620","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.omto.2021.07.013","article-title":"A novel protein-drug conjugate, SSH20, demonstrates significant efficacy in caveolin-1-expressing tumors","volume":"22","author":"Robb","year":"2021","journal-title":"Mol. Therapy-Oncol."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0625","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2013.02.030","article-title":"Approaches for enhancing oral bioavailability of peptides and proteins","volume":"447","author":"Renukuntla","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.01.019_bb0630","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.3390\/molecules23102615","article-title":"Amide bond activation of biological molecules","volume":"23","author":"Mahesh","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2025.01.019_bb0635","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8891373","article-title":"Albumin reduces oxidative stress and neuronal apoptosis via the ERK\/Nrf2\/HO-1 pathway after intracerebral hemorrhage in rats","volume":"2021","author":"Deng","year":"2021","journal-title":"Oxidative Med. Cell. Longev."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925000215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925000215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T12:30:12Z","timestamp":1762259412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925000215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":127,"alternative-id":["S0168365925000215"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.019","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human serum albumin-3-amino-1-propanesulfonic acid conjugate inhibits amyloid-\u03b2 aggregation and mitigates cognitive decline in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}